ESCaping Rejection: A Step Forward for Embryonic-Stem-Cell-Based Regenerative Medicine

详细信息    查看全文

• 作者：Tim Willinger ; Richard聽A. Flavell
• 刊名：Cell Stem Cell
• 出版年：2 January, 2014
• 年：2014
• 卷：14
• 期：1
• 页码：3-4
• 全文大小：282 K

文摘

The use of human embryonic stem cells (hESCs) for regenerative medicine currently faces several hurdles, including immune rejection of transplanted cells. Now in Cell Stem Cell, describe a strategy to protect hESCs from immune rejection while avoiding systemic immunosuppression, potentially facilitating clinical implementation of hESC-based therapies.